Lapatinib Terminated Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00073008A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer